Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort

Background: Hepatocellular carcinoma (HCC), the most prevalent form of liver cancer, is difficult to diagnose and has limited treatment options with a low survival rate. Aside from a few key risk factors, such as hepatitis, high alcohol consumption, smoking, obesity, and diabetes, there is incomplete etiologic understanding of the disease and little progress in identification of early risk biomarkers. Methods: To address these aspects, an untargeted nuclear magnetic resonance metabolomic approach was applied to pre-diagnostic serum samples obtained from first incident, primary HCC cases (n = 114) and matched controls (n = 222) identified from amongst the participants of a large European prospective cohort. Results: A metabolic pattern associated with HCC risk comprised of perturbations in fatty acid oxidation and amino acid, lipid, and carbohydrate metabolism was observed. Sixteen metabolites of either endogenous or exogenous origin were found to be significantly associated with HCC risk. The influence of hepatitis infection and potential liver damage was assessed, and further analyses were made to distinguish patterns of early or later diagnosis. Conclusion: Our results show clear metabolic alterations from early stages of HCC development with application for better etiologic understanding, prevention, and early detection of this increasingly common cancer.This work was supported by the French National Cancer Institute (L’Institut National du Cancer; INCA; grant number 2009-139; PI: M. Jenab). AF received financial support (BDI fellowship) from the Centre National de la Recherche Scientifique (CNRS) and Bruker Biospin. The coordination of EPIC is financially supported by the European Commission (DG-SANCO) and the International Agency for Research on Cancer. The national cohorts are supported by Danish Cancer Society (Denmark); Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle Générale de l’Education Nationale, and Institut National de la Santé et de la Recherche Médicale (INSERM) (France); Deutsche Krebshilfe, Deutsches Krebsforschungszentrum (DKFZ), and Federal Ministry of Education and Research (Germany); Hellenic Health Foundation (Greece); Italian Association for Research on Cancer (AIRC), National Research Council, Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy, and AIRE-ONLUS Ragusa, AVIS Ragusa, Sicilian Government (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF), and Statistics Netherlands (the Netherlands); European Research Council (ERC; grant number ERC-2009-AdG 232997) and Nordforsk, and Nordic Center of Excellence Programme on Food, Nutrition and Health (Norway); Health Research Fund (FIS), Regional Governments of Andalucía, Asturias, Basque Country, Murcia (No. 6236) and Navarra, and ISCIII RETIC (RD06/0020) (Spain); Swedish Cancer Society, Swedish Scientific Council, and Regional Government of Skåne and Västerbotten (Sweden); Cancer Research UK, Medical Research Council, Stroke Association, British Heart Foundation, Department of Health, Food Standards Agency, and Wellcome Trust (UK)

Métabolomique par chromatographie en phase gazeuse couplée à la spectrométrie de masse et désordres génomiques détectés par CGH array : biomarqueurs ou mécanismes

The aim of this pilot study is to assess the effects of genomic disorders at the metabolic level to derive metabolic markers and suggest pathological mechanisms. We analysed urinary organic acids by mass spectrometry coupled to gas chromatography in 30 patients carrying a genomic disorder. We observed in a patient carrying a 22q13.2qter deletion an increase in uracil and thymine due to the deletion of the TYMP gene found in this disorder. We found a decrease in N-acetylaspartic acid in a patient carrying a complex genomic disorder deleting one copy of the gene N8TL, explaining the biochemical phenotype. Noteworthy, TYMP and NAT8L are close to the haploinsufficient genes SHANK3 and NSD2. These metabolic signatures could thus be considered as indirect markers of SHANK3 and NSD2 deletions. These results need to be validated in a larger cohort. This study highlights the possibility of moderate variations of intermediary metabolism due to genetic causes and asks the question of their involvement in the phenotypes of patients.L’objectif de cette étude pilote est d’étudier l’impact des désordres génomiques au niveau métabolique afin de mettre en évidence des marqueurs diagnostiques et de proposer des pistes de mécanismes physiopathologiques. Nous avons analysés les profils d’acides organiques urinaires mesurés par chromatographie en phase gazeuse couplée à la spectrométrie de masse de 30 patients porteurs de désordres génomiques détectés par CGH array. Nous avons observé une augmentation des concentrations urinaires de l’uracile et de la thymine chez une patiente présentant une délétion 22q13.2qter en rapport avec la délétion du gène TYMP retrouvé dans ce désordre génomique. Une diminution de l’acide N-acetylaspartique urinaire est retrouvée chez un patient porteur d’un désordre chromosomique complexe emportant une copie du gène NAT8L expliquant le phénotype métabolique. De manière intéressante, TYMP et NAT8L sont situés à proximité des gènes SHANK3 et NSD2. Les signatures métaboliques observées pourraient donc être utilisées comme marqueurs indirects des délétions de SHANK3 et NSD2. Ces résultats sont à valider avec un nombre plus grand de patients. Cette étude illustre la possibilité de variations modérées du métabolisme intermédiaire, secondaires à des causes génétiques et pose la question de leurs implications dans le phénotype présenté par les patients

Métabolomique par RMN à très hauts champs : phénotypage de la complexité métabolique de l’Homme à la cellule

This thesis is dedicated to developments and applications of metabolomics, exploiting high field NMR spectroscopy. The first part is dedicated to a general presentation of metabolomics. We also report results about the introduction of reduced dimensionality techniques for the characterization of complex mixtures, coined targeted projection NMR spectroscopy. The second part of this manuscript reports results about three different metabolomic studies carried out in human populations. The first analysis demonstrates the suitability for metabolomics of serum samples collected in the framework of the European Prospective Investigation into Cancer and Nutrition (EPIC) study. The second study investigates a serum metabolic signature of metastatic breast cancer. The last analysis establishes potential plasma metabolic signatures for different liver pathologies, like hepatocellular carcinoma. The third part of this thesis is dedicated to the characterization of various model organisms. The first study presents a characterization of plasma and urine metabolic differences between four rat strains commonly used as controls in genetic studies. In the second study, we investigate the effects of physiological aging in Caenorhabditis elegans (C. elegans) and observe that dietary restriction buffers metabolic changes associated with aging. We further identify that perturbations in phosphocholine metabolism correlate with life expectancy. The third analysis of this part characterizes the ahr-1 C. elegans mutant, showing strong metabolic changes in ahr-1 mutants, which suggest an involvement in development and aging processes. We finally investigate in the last study the effects at the metabolic level of the interaction between an endogenous protein E4F1 and a viral protein HBx in liver cells infected by hepatitis B virus.Cette thèse est dédiée aux développements méthodologiques et applications de la métabolomique par Résonance Magnétique Nucléaire (RMN) à très hauts champs. La première partie de ce manuscrit est dédiée à une présentation générale de la métabolomique par RMN. Nous décrivons ensuite les résultats obtenus concernant l’introduction d’une technique à dimensionnalité réduite pour la caractérisation des mélanges complexes, dénommée spectroscopie RMN par projections ciblées. La seconde partie de ce manuscrit décrit les résultats de trois études métabolomiques portant sur des populations humaines. La première analyse démontre que les échantillons de sérum collectés dans le cadre de la cohorte européenne prospective internationale EPIC sont appropriés pour une étude métabolomique. Les deux études suivantes recherchent une signature métabolique dans le sérum du cancer du sein métastatique et une signature plasmatique potentielle pour différentes pathologies hépatiques comme le carcinome hépatocellulaire. La troisième partie de cette thèse est dédiée à l’étude d’organismes modèles. La première étude caractérise les différences métaboliques systémiques entre quatre souches de rats couramment utilisées comme contrôles en génétique. Dans la seconde analyse, nous étudions les effets du vieillissement physiologique chez Caenorhabditis elegans (C. elegans), observons que le processus de restriction alimentaire tamponne les modifications métaboliques associées au vieillissement et que des perturbations du métabolisme de la phosphocholine corrèlent avec l’espérance de vie. La troisième étude caractérise des modifications métaboliques importantes chez un mutant de C. elegans, pour le gène ahr-1, suggérant un rôle dans le développement et le vieillissement. Enfin, nous étudions les effets au niveau métabolique de l’interaction entre la protéine endogène E4F1 et la protéine virale HBx dans des cellules hépatiques infectées par le virus de l’hépatite B

Métabolomique par RMN à très hauts champs (phénotypage de la complexité métabolique de l Homme à la cellule)

Cette thèse est dédiée aux développements méthodologiques et applications de la métabolomique par Résonance Magnétique Nucléaire (RMN) à très hauts champs. La première partie de ce manuscrit est dédiée à une présentation générale de la métabolomique par RMN. Nous décrivons ensuite les résultats obtenus concernant l introduction d une technique à dimensionnalité réduite pour la caractérisation des mélanges complexes, dénommée spectroscopie RMN par projections ciblées. La seconde partie de ce manuscrit décrit les résultats de trois études métabolomiques portant sur des populations humaines. La première analyse démontre que les échantillons de sérum collectés dans le cadre de la cohorte européenne prospective internationale EPIC sont appropriés pour une étude métabolomique. Les deux études suivantes recherchent une signature métabolique dans le sérum du cancer du sein métastatique et une signature plasmatique potentielle pour différentes pathologies hépatiques comme le carcinome hépatocellulaire. La troisième partie de cette thèse est dédiée à l étude d organismes modèles. La première étude caractérise les différences métaboliques systémiques entre quatre souches de rats couramment utilisées comme contrôles en génétique. Dans la seconde analyse, nous étudions les effets du vieillissement physiologique chez Caenorhabditis elegans (C. elegans), observons que le processus de restriction alimentaire tamponne les modifications métaboliques associées au vieillissement et que des perturbations du métabolisme de la phosphocholine corrèlent avec l espérance de vie. La troisième étude caractérise des modifications métaboliques importantes chez un mutant de C. elegans, pour le gène ahr-1, suggérant un rôle dans le développement et le vieillissement. Enfin, nous étudions les effets au niveau métabolique de l interaction entre la protéine endogène E4F1 et la protéine virale HBx dans des cellules hépatiques infectées par le virus de l hépatite B.This thesis is dedicated to developments and applications of metabolomics, exploiting high field NMR spectroscopy. The first part is dedicated to a general presentation of metabolomics. We also report results about the introduction of reduced dimensionality techniques for the characterization of complex mixtures, coined targeted projection NMR spectroscopy. The second part of this manuscript reports results about three different metabolomic studies carried out in human populations. The first analysis demonstrates the suitability for metabolomics of serum samples collected in the framework of the European Prospective Investigation into Cancer and Nutrition (EPIC) study. The second study investigates a serum metabolic signature of metastatic breast cancer. The last analysis establishes potential plasma metabolic signatures for different liver pathologies, like hepatocellular carcinoma. The third part of this thesis is dedicated to the characterization of various model organisms. The first study presents a characterization of plasma and urine metabolic differences between four rat strains commonly used as controls in genetic studies. In the second study, we investigate the effects of physiological aging in Caenorhabditis elegans (C. elegans) and observe that dietary restriction buffers metabolic changes associated with aging. We further identify that perturbations in phosphocholine metabolism correlate with life expectancy. The third analysis of this part characterizes the ahr-1 C. elegans mutant, showing strong metabolic changes in ahr-1 mutants, which suggest an involvement in development and aging processes. We finally investigate in the last study the effects at the metabolic level of the interaction between an endogenous protein E4F1 and a viral protein HBx in liver cells infected by hepatitis B virus.LYON-ENS Sciences (693872304) / SudocSudocFranceF

Proportionally dense subgraph of maximum size

We define a proportionally dense subgraph (PDS) as an induced subgraph of a graph with the property that each vertex in the PDS is adjacent to proportionally as many vertices in the subgraph as in the graph. We prove that the problem of finding a PDS of maximum size is APX-hard on split graphs, and NP-hard on bipartite graphs. We also show that deciding if a PDS is inclusion-wise maximal is co-NP-complete on bipartite graphs. Nevertheless, we present a simple polynomial-time $(2-\frac{2}{\Delta+1})$-approximation algorithm for the problem, where $\Delta$ is the maximum degree of the graph. Finally, we show that all Hamiltonian cubic graphs with $n$ vertices (except two) have a PDS of size $\lfloor \frac{2n+1}{3} \rfloor$, which we prove to be an upper bound on the size of a PDS in cubic graphs

Batch profiling calibration for robust NMR metabonomic data analysis.

International audienceMetabonomic studies involve the analysis of large numbers of samples to identify significant changes in the metabolic fingerprints of biological systems, possibly with sufficient statistical power for analysis. While procedures related to sample preparation and spectral data acquisition generally include the use of independent sample batches, these might be sources of systematic variation whose effects should be removed to focus on phenotyping the relevant biological variability. In this work, we describe a grouped-batch profile (GBP) calibration strategy to adjust nuclear magnetic resonance (NMR) metabolomic data-sets for batch effects either introduced during NMR experiments or samples work-up. We show how this method can be applied to data calibration in the context of a large-scale NMR epidemiological study where quality control samples are available. We also illustrate the efficiency of a batch profile correction for NMR metabonomic investigation of cell extracts, where GBP can significantly improve the predictive power of multivariate statistical models for discriminant analysis of the cell infection status. The method is applicable to a broad range of NMR metabolomic/metabonomic cohort studies

Metabolomics analysis uncovers that dietary restriction buffers metabolic changes associated with aging in Caenorhabditis elegans

Dietary restriction (DR) is one of the most universal means of extending lifespan. Yet, whether and how DR specifically affects the metabolic changes associated with aging is essentially unknown. Here, we present a comprehensive and unbiased picture of the metabolic variations that take place with age at the whole organism level in Caenorhabditis elegans by using (1)H high-resolution magic-angle spinning (HR-MAS) nuclear magnetic resonance (NMR) analysis of intact worms. We investigate metabolic variations potentially important for lifespan regulation by comparing the metabolic fingerprint of two previously described genetic models of DR, the long-lived eat-2(ad465) and slcf-1(tm2258) worms, as single mutants or in combination with a genetic suppressor of their lifespan phenotype. Our analysis shows that significant changes in metabolite profiles precede the major physiological decline that accompanies aging and that DR protects from some of those metabolic changes. More specifically, low phosphocholine (PCho) correlates with high life expectancy. A mutation in the tumor suppressor gene PTEN/DAF-18, which suppresses the beneficial effects of DR in both C. elegans and mammals, increases both PCho level and choline kinase expression. Furthermore, we show that choline kinase function in the intestine can regulate lifespan. This study highlights the relevance of NMR metabolomic approaches for identifying potential biomarkers of aging

Cystathionine as a marker for 1p/19q codeleted gliomas by in vivo magnetic resonance spectroscopy

International audienceBackground: Codeletion of chromosome arms 1p and 19q (1p/19q codeletion) highly benefits diagnosis and prognosis in gliomas. In this study, we investigated the effect of 1p/19q codeletion on cancer cell metabolism and evaluated possible metabolic targets for tailored therapies.Methods: We combined in vivo 1H (proton) magnetic resonance spectroscopy (MRS) measurements in human gliomas with the analysis of a series of standard amino acids by liquid chromatography-mass spectroscopy (LC-MS) in human glioma biopsies. Sixty-five subjects with low-grade glioma were included in the study: 31 underwent the MRI/MRS examination, 47 brain tumor tissue samples were analyzed with LC-MS, and 33 samples were analyzed for gene expression with quantitative PCR. Additionally, we performed metabolic tracer experiments in cell models with 1p deletion.Results: We report the first in vivo detection of cystathionine by MRS in 1p/19q codeleted gliomas. Selective accumulation of cystathionine was observed in codeleted gliomas in vivo, in brain tissue samples, as well as in cells harboring heterozygous deletions for serine- and cystathionine-pathway genes located on 1p: phosphoglycerate dehydrogenase (PHGDH) and cystathionine gamma-lyase (CTH). Quantitative PCR analyses showed 40-50% lower expression of both PHGDH and CTH in 1p/19q codeleted gliomas compared with their non-codeleted counterparts.Conclusions: Our results provide strong evidence of a selective vulnerability of codeleted gliomas to serine and glutathione depletion and point to cystathionine as a possible noninvasive marker of treatment response

Citrulline in the management of patients with urea cycle disorders

Abstract Background Treatment recommendations for urea cycle disorders (UCDs) include supplementation with amino acids involved in the urea cycle (arginine and/or citrulline, depending on the enzyme deficiency), to maximize ammonia excretion through the urea cycle, but limited data are available regarding the use of citrulline. This study retrospectively reviewed clinical and biological data from patients with UCDs treated with citrulline and/or arginine at a reference center since 1990. The aim was to describe the prescription, impact, and safety of these therapies. Data collection included patient background, treatment details, changes in biochemical parameters (plasma ammonia and amino acids concentrations), decompensations, and patient outcomes. Results Overall, 79 patients (median age at diagnosis, 0.9 months) received citrulline and/or arginine in combination with a restricted protein diet, most with ornithine transcarbamylase (n = 57, 73%) or carbamoyl phosphate synthetase 1 (n = 15, 19%) deficiencies. Most patients also received ammonium scavengers. Median follow-up was 9.5 years and median exposure to first treatment with arginine + citrulline, citrulline monotherapy, or arginine monotherapy was 5.5, 2.5, or 0.3 years, respectively. During follow-up, arginine or citrulline was administered at least once (as monotherapy or in combination) in the same proportion of patients (86.1%); the overall median duration of exposure was 5.9 years for arginine + citrulline, 3.1 years for citrulline monotherapy, and 0.6 years for arginine monotherapy. The most common switch was from monotherapy to combination therapy (41 of 75 switches, 54.7%). During treatment, mean ammonia concentrations were 35.9 µmol/L with citrulline, 49.8 µmol/L with arginine, and 53.0 µmol/L with arginine + citrulline. Mean plasma arginine concentrations increased significantly from the beginning to the end of citrulline treatment periods (from 67.6 µmol/L to 84.9 µmol/L, P < 0.05). At last evaluation, mean height and weight for age were normal and most patients showed normal or adapted behavior (98.7%) and normal social life (79.0%). Two patients (2.5%) experienced three treatment-related gastrointestinal adverse reactions. Conclusions This study underlines the importance of citrulline supplementation, either alone or together with arginine, in the management of patients with UCDs. When a monotherapy is considered, citrulline would be the preferred option in terms of increasing plasma arginine concentrations